16.12.2021 - Waltham, MA, Dec. 16, 2021 (GLOBE NEWSWIRE) - LAVA Medtech Acquisition Corp. (the “Company”) (NASDAQ: LVACU) announced today that, commencing December 17, 2021, holders of the units sold in the Company’s initial public offering may elect to .